

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 7.30696322 |
| 2 | omega-hydroxylase P450 pathway (GO:0097267) | 6.74790739 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.70889681 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 6.70889681 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.35566940 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 6.35566940 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.12510954 |
| 8 | * regulation of protein activation cascade (GO:2000257) | 5.85415291 |
| 9 | * complement activation, alternative pathway (GO:0006957) | 5.82975202 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.76188693 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 5.66739230 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 5.66739230 |
| 13 | tryptophan catabolic process (GO:0006569) | 5.66739230 |
| 14 | * regulation of complement activation (GO:0030449) | 5.57917526 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.52342031 |
| 16 | kynurenine metabolic process (GO:0070189) | 5.50631721 |
| 17 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.44083652 |
| 18 | protein carboxylation (GO:0018214) | 5.44083652 |
| 19 | tryptophan metabolic process (GO:0006568) | 5.40980089 |
| 20 | homocysteine metabolic process (GO:0050667) | 5.35248372 |
| 21 | glyoxylate metabolic process (GO:0046487) | 5.27759052 |
| 22 | negative regulation of fibrinolysis (GO:0051918) | 5.20493090 |
| 23 | urea metabolic process (GO:0019627) | 5.19558072 |
| 24 | urea cycle (GO:0000050) | 5.19558072 |
| 25 | regulation of fibrinolysis (GO:0051917) | 5.10385635 |
| 26 | alpha-linolenic acid metabolic process (GO:0036109) | 5.10042697 |
| 27 | high-density lipoprotein particle remodeling (GO:0034375) | 5.01502705 |
| 28 | sulfur amino acid catabolic process (GO:0000098) | 4.81871413 |
| 29 | regulation of plasminogen activation (GO:0010755) | 4.77017607 |
| 30 | * regulation of humoral immune response (GO:0002920) | 4.76110107 |
| 31 | nitrogen cycle metabolic process (GO:0071941) | 4.75497849 |
| 32 | cysteine metabolic process (GO:0006534) | 4.71480786 |
| 33 | bile acid metabolic process (GO:0008206) | 4.69359480 |
| 34 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.64747543 |
| 35 | negative regulation of blood coagulation (GO:0030195) | 4.63879396 |
| 36 | negative regulation of hemostasis (GO:1900047) | 4.63879396 |
| 37 | oxidative demethylation (GO:0070989) | 4.61310957 |
| 38 | ethanol metabolic process (GO:0006067) | 4.57786674 |
| 39 | reverse cholesterol transport (GO:0043691) | 4.54506847 |
| 40 | negative regulation of protein activation cascade (GO:2000258) | 4.44814268 |
| 41 | hormone catabolic process (GO:0042447) | 4.42580691 |
| 42 | aromatic amino acid family metabolic process (GO:0009072) | 4.41222135 |
| 43 | serine family amino acid catabolic process (GO:0009071) | 4.39768080 |
| 44 | regulation of triglyceride catabolic process (GO:0010896) | 4.39013906 |
| 45 | tyrosine metabolic process (GO:0006570) | 4.37765594 |
| 46 | regulation of cholesterol esterification (GO:0010872) | 4.37212883 |
| 47 | phospholipid efflux (GO:0033700) | 4.32806694 |
| 48 | protein-lipid complex remodeling (GO:0034368) | 4.32578032 |
| 49 | macromolecular complex remodeling (GO:0034367) | 4.32578032 |
| 50 | plasma lipoprotein particle remodeling (GO:0034369) | 4.32578032 |
| 51 | negative regulation of wound healing (GO:0061045) | 4.32347940 |
| 52 | bile acid and bile salt transport (GO:0015721) | 4.31525484 |
| 53 | negative regulation of coagulation (GO:0050819) | 4.30117430 |
| 54 | complement activation, classical pathway (GO:0006958) | 4.29988515 |
| 55 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.27036854 |
| 56 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.26443329 |
| 57 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.26443329 |
| 58 | lysine metabolic process (GO:0006553) | 4.26011165 |
| 59 | lysine catabolic process (GO:0006554) | 4.26011165 |
| 60 | triglyceride homeostasis (GO:0070328) | 4.21226030 |
| 61 | acylglycerol homeostasis (GO:0055090) | 4.21226030 |
| 62 | regulation of apoptotic cell clearance (GO:2000425) | 4.20559848 |
| 63 | amino-acid betaine metabolic process (GO:0006577) | 4.19625825 |
| 64 | fibrinolysis (GO:0042730) | 4.17944321 |
| 65 | * complement activation (GO:0006956) | 4.17238566 |
| 66 | plasma lipoprotein particle clearance (GO:0034381) | 4.14362469 |
| 67 | alpha-amino acid catabolic process (GO:1901606) | 4.09800059 |
| 68 | cellular glucuronidation (GO:0052695) | 4.02999669 |
| 69 | indolalkylamine metabolic process (GO:0006586) | 4.01260804 |
| 70 | negative regulation of sterol transport (GO:0032372) | 4.00021750 |
| 71 | negative regulation of cholesterol transport (GO:0032375) | 4.00021750 |
| 72 | cholesterol efflux (GO:0033344) | 3.99155825 |
| 73 | amine catabolic process (GO:0009310) | 3.96466755 |
| 74 | cellular biogenic amine catabolic process (GO:0042402) | 3.96466755 |
| 75 | phenylpropanoid metabolic process (GO:0009698) | 3.94774710 |
| 76 | * protein activation cascade (GO:0072376) | 3.91330918 |
| 77 | daunorubicin metabolic process (GO:0044597) | 3.90859345 |
| 78 | polyketide metabolic process (GO:0030638) | 3.90859345 |
| 79 | doxorubicin metabolic process (GO:0044598) | 3.90859345 |
| 80 | benzene-containing compound metabolic process (GO:0042537) | 3.88619357 |
| 81 | negative regulation of humoral immune response (GO:0002921) | 3.85855718 |
| 82 | positive regulation of hemostasis (GO:1900048) | 3.85248586 |
| 83 | positive regulation of blood coagulation (GO:0030194) | 3.85248586 |
| 84 | cellular ketone body metabolic process (GO:0046950) | 3.84128894 |
| 85 | opsonization (GO:0008228) | 3.82238173 |
| 86 | blood coagulation, intrinsic pathway (GO:0007597) | 3.79826028 |
| 87 | coenzyme catabolic process (GO:0009109) | 3.79693318 |
| 88 | phospholipid homeostasis (GO:0055091) | 3.79281076 |
| 89 | cellular amino acid catabolic process (GO:0009063) | 3.77984136 |
| 90 | imidazole-containing compound metabolic process (GO:0052803) | 3.75758808 |
| 91 | plasma lipoprotein particle assembly (GO:0034377) | 3.74888120 |
| 92 | cellular modified amino acid catabolic process (GO:0042219) | 3.73638074 |
| 93 | ethanol oxidation (GO:0006069) | 3.73384376 |
| 94 | low-density lipoprotein particle remodeling (GO:0034374) | 3.72788107 |
| 95 | glutamate metabolic process (GO:0006536) | 3.70983372 |
| 96 | negative regulation of complement activation (GO:0045916) | 3.68077073 |
| 97 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.61825392 |
| 98 | flavonoid metabolic process (GO:0009812) | 3.61291697 |
| 99 | primary alcohol catabolic process (GO:0034310) | 3.60533812 |
| 100 | positive regulation of coagulation (GO:0050820) | 3.56743862 |
| 101 | glucuronate metabolic process (GO:0019585) | 3.56262304 |
| 102 | uronic acid metabolic process (GO:0006063) | 3.56262304 |
| 103 | glycine metabolic process (GO:0006544) | 3.54822341 |
| 104 | arginine metabolic process (GO:0006525) | 3.53391653 |
| 105 | cytolysis (GO:0019835) | 3.52165780 |
| 106 | acute inflammatory response (GO:0002526) | 3.51142863 |
| 107 | positive regulation of lipid catabolic process (GO:0050996) | 3.51129078 |
| 108 | cholesterol homeostasis (GO:0042632) | 3.50815624 |
| 109 | negative regulation of lipase activity (GO:0060192) | 3.47362116 |
| 110 | * regulation of acute inflammatory response (GO:0002673) | 3.47041036 |
| 111 | drug catabolic process (GO:0042737) | 3.46873631 |
| 112 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.45518522 |
| 113 | sterol homeostasis (GO:0055092) | 3.45307143 |
| 114 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.44924076 |
| 115 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.44432303 |
| 116 | serine family amino acid metabolic process (GO:0009069) | 3.42592119 |
| 117 | drug metabolic process (GO:0017144) | 3.42106417 |
| 118 | regulation of bile acid biosynthetic process (GO:0070857) | 3.41050065 |
| 119 | acute-phase response (GO:0006953) | 3.40208899 |
| 120 | protein-lipid complex assembly (GO:0065005) | 3.39963658 |
| 121 | epoxygenase P450 pathway (GO:0019373) | 3.36878094 |
| 122 | plasma lipoprotein particle organization (GO:0071827) | 3.36861798 |
| 123 | S-adenosylmethionine metabolic process (GO:0046500) | 3.36181659 |
| 124 | organic acid catabolic process (GO:0016054) | 3.35864486 |
| 125 | carboxylic acid catabolic process (GO:0046395) | 3.35864486 |
| 126 | alkaloid metabolic process (GO:0009820) | 3.33891464 |
| 127 | cofactor catabolic process (GO:0051187) | 3.32662652 |
| 128 | aldehyde catabolic process (GO:0046185) | 3.31569683 |
| 129 | ketone body metabolic process (GO:1902224) | 3.30801972 |
| 130 | lipoprotein metabolic process (GO:0042157) | 3.30059405 |
| 131 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.15210938 |
| 132 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.15172412 |
| 133 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.15172412 |
| 134 | arginine catabolic process (GO:0006527) | 3.14906719 |
| 135 | xenobiotic metabolic process (GO:0006805) | 3.13725819 |
| 136 | response to mercury ion (GO:0046689) | 3.11289196 |
| 137 | primary alcohol metabolic process (GO:0034308) | 3.04852661 |
| 138 | regulation of hemostasis (GO:1900046) | 3.02921203 |
| 139 | regulation of blood coagulation (GO:0030193) | 3.02921203 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.32199289 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.19627983 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.11007834 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.89602381 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.54401144 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.33590230 |
| 7 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.06787736 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.84167869 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.02891129 |
| 10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.27384404 |
| 11 | GATA1_22025678_ChIP-Seq_K562_Human | 2.22730459 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.2669512 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.87361382 |
| 14 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.73330469 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.69003276 |
| 16 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.65311928 |
| 17 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.56183869 |
| 18 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.56094481 |
| 19 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.54089853 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.53199996 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.47838844 |
| 22 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.47174738 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.38616451 |
| 24 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.38172621 |
| 25 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.34312678 |
| 26 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.32323770 |
| 27 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.32081898 |
| 28 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.30589799 |
| 29 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.23941853 |
| 30 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.23359726 |
| 31 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.23267624 |
| 32 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.22258574 |
| 33 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.20908547 |
| 34 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.19961044 |
| 35 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.19593862 |
| 36 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.19572014 |
| 37 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.12945636 |
| 38 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.12945636 |
| 39 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.12164344 |
| 40 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.07999263 |
| 41 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.05049759 |
| 42 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.04943592 |
| 43 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.01982710 |
| 44 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.98186109 |
| 45 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95343042 |
| 46 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.92389098 |
| 47 | TP53_16413492_ChIP-PET_HCT116_Human | 0.91526472 |
| 48 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.91309591 |
| 49 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.90908199 |
| 50 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.90821745 |
| 51 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.90110002 |
| 52 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.89580553 |
| 53 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.88718407 |
| 54 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.86447025 |
| 55 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.84792512 |
| 56 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.83932366 |
| 57 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.83725551 |
| 58 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.83188428 |
| 59 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.81070845 |
| 60 | * PHF8_20622853_ChIP-Seq_HELA_Human | 0.80738088 |
| 61 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.80679073 |
| 62 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.80059748 |
| 63 | CJUN_26792858_Chip-Seq_BT549_Human | 0.79057667 |
| 64 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.78838281 |
| 65 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.78722199 |
| 66 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.78309745 |
| 67 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.78193098 |
| 68 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.75012311 |
| 69 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.74873683 |
| 70 | * NFYA_21822215_ChIP-Seq_K562_Human | 0.74801063 |
| 71 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.73988798 |
| 72 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.73805723 |
| 73 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.73120385 |
| 74 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.72209472 |
| 75 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.71872011 |
| 76 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.71093633 |
| 77 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.70966960 |
| 78 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.70929049 |
| 79 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.70701089 |
| 80 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.69512642 |
| 81 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.68766214 |
| 82 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.68572092 |
| 83 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.68572092 |
| 84 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.67118719 |
| 85 | * ETV1_20927104_ChIP-Seq_GIST48_Human | 0.65713384 |
| 86 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.64623880 |
| 87 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.64298306 |
| 88 | GATA1_19941826_ChIP-Seq_K562_Human | 0.64208951 |
| 89 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.63172974 |
| 90 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.62982559 |
| 91 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.62585450 |
| 92 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.62490667 |
| 93 | GATA2_19941826_ChIP-Seq_K562_Human | 0.61868412 |
| 94 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.61590470 |
| 95 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.60757603 |
| 96 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.59130008 |
| 97 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.58668330 |
| 98 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.56611944 |
| 99 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.55927925 |
| 100 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.55104881 |
| 101 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.54315353 |
| 102 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.54014341 |
| 103 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.54014341 |
| 104 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.53215484 |
| 105 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.52793013 |
| 106 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.51979402 |
| 107 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.51869452 |
| 108 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.51494690 |
| 109 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.51390400 |
| 110 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.50592962 |
| 111 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.49738973 |
| 112 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.48768456 |
| 113 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.48734058 |
| 114 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.48629769 |
| 115 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.48378240 |
| 116 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.48356009 |
| 117 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.47919601 |
| 118 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.47765054 |
| 119 | AR_20517297_ChIP-Seq_VCAP_Human | 0.47639182 |
| 120 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.47064469 |
| 121 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.46446068 |
| 122 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.45890806 |
| 123 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.45357506 |
| 124 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.45297363 |
| 125 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.43201295 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.35873083 |
| 2 | MP0005360_urolithiasis | 6.70861567 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.92103566 |
| 4 | MP0005365_abnormal_bile_salt | 5.49562710 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.51933195 |
| 6 | MP0003252_abnormal_bile_duct | 4.09644235 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.42007848 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.30257980 |
| 9 | MP0003195_calcinosis | 2.99857246 |
| 10 | MP0009840_abnormal_foam_cell | 2.99114107 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.75219057 |
| 12 | MP0008438_abnormal_cutaneous_collagen | 2.62361666 |
| 13 | MP0005332_abnormal_amino_acid | 2.59773316 |
| 14 | MP0005083_abnormal_biliary_tract | 2.50698579 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.19475796 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.10268748 |
| 17 | MP0000609_abnormal_liver_physiology | 2.04727909 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.02386695 |
| 19 | MP0010368_abnormal_lymphatic_system | 1.97910257 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 1.96656734 |
| 21 | MP0005319_abnormal_enzyme/_coenzyme | 1.72170874 |
| 22 | MP0005275_abnormal_skin_tensile | 1.71735031 |
| 23 | MP0003868_abnormal_feces_composition | 1.50224340 |
| 24 | MP0005503_abnormal_tendon_morphology | 1.48669412 |
| 25 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.45265832 |
| 26 | MP0003705_abnormal_hypodermis_morpholog | 1.41575314 |
| 27 | MP0001764_abnormal_homeostasis | 1.31223944 |
| 28 | MP0009697_abnormal_copulation | 1.28627285 |
| 29 | MP0003011_delayed_dark_adaptation | 1.25766034 |
| 30 | MP0002254_reproductive_system_inflammat | 1.20448251 |
| 31 | * MP0009643_abnormal_urine_homeostasis | 1.20242469 |
| 32 | MP0005647_abnormal_sex_gland | 1.17427809 |
| 33 | MP0009764_decreased_sensitivity_to | 1.16803408 |
| 34 | MP0003656_abnormal_erythrocyte_physiolo | 1.11811307 |
| 35 | MP0000598_abnormal_liver_morphology | 1.11016989 |
| 36 | MP0000604_amyloidosis | 1.05741806 |
| 37 | MP0009763_increased_sensitivity_to | 1.05329864 |
| 38 | MP0003690_abnormal_glial_cell | 1.05264174 |
| 39 | MP0003724_increased_susceptibility_to | 1.03250620 |
| 40 | MP0005670_abnormal_white_adipose | 0.98239897 |
| 41 | MP0003186_abnormal_redox_activity | 0.97074044 |
| 42 | MP0005257_abnormal_intraocular_pressure | 0.97000720 |
| 43 | MP0002132_abnormal_respiratory_system | 0.94802025 |
| 44 | MP0006082_CNS_inflammation | 0.94650701 |
| 45 | * MP0008469_abnormal_protein_level | 0.94645139 |
| 46 | MP0001661_extended_life_span | 0.92872158 |
| 47 | MP0003566_abnormal_cell_adhesion | 0.91448994 |
| 48 | MP0005451_abnormal_body_composition | 0.88382797 |
| 49 | MP0003950_abnormal_plasma_membrane | 0.85113086 |
| 50 | * MP0009642_abnormal_blood_homeostasis | 0.84689884 |
| 51 | MP0003075_altered_response_to | 0.84151221 |
| 52 | MP0005636_abnormal_mineral_homeostasis | 0.83848286 |
| 53 | MP0004130_abnormal_muscle_cell | 0.82645377 |
| 54 | MP0004883_abnormal_blood_vessel | 0.81405443 |
| 55 | MP0005058_abnormal_lysosome_morphology | 0.81152293 |
| 56 | MP0005464_abnormal_platelet_physiology | 0.81012466 |
| 57 | MP0005084_abnormal_gallbladder_morpholo | 0.77239200 |
| 58 | MP0002060_abnormal_skin_morphology | 0.75830737 |
| 59 | MP0002282_abnormal_trachea_morphology | 0.75529447 |
| 60 | MP0001756_abnormal_urination | 0.74788462 |
| 61 | MP0003436_decreased_susceptibility_to | 0.72656553 |
| 62 | MP0005220_abnormal_exocrine_pancreas | 0.72259163 |
| 63 | MP0000751_myopathy | 0.72205877 |
| 64 | MP0009053_abnormal_anal_canal | 0.71217753 |
| 65 | MP0002933_joint_inflammation | 0.70733870 |
| 66 | MP0005376_homeostasis/metabolism_phenot | 0.70050360 |
| 67 | MP0005334_abnormal_fat_pad | 0.69341553 |
| 68 | MP0002928_abnormal_bile_duct | 0.68801593 |
| 69 | MP0000249_abnormal_blood_vessel | 0.68644986 |
| 70 | MP0000639_abnormal_adrenal_gland | 0.68395814 |
| 71 | MP0002971_abnormal_brown_adipose | 0.67137364 |
| 72 | MP0009384_cardiac_valve_regurgitation | 0.67129918 |
| 73 | MP0005164_abnormal_response_to | 0.66666039 |
| 74 | MP0002295_abnormal_pulmonary_circulatio | 0.66033699 |
| 75 | MP0002128_abnormal_blood_circulation | 0.65626508 |
| 76 | MP0005166_decreased_susceptibility_to | 0.64965004 |
| 77 | MP0005167_abnormal_blood-brain_barrier | 0.64631844 |
| 78 | MP0009765_abnormal_xenobiotic_induced | 0.63978544 |
| 79 | MP0005165_increased_susceptibility_to | 0.63909651 |
| 80 | MP0005023_abnormal_wound_healing | 0.63505392 |
| 81 | MP0001879_abnormal_lymphatic_vessel | 0.63340202 |
| 82 | MP0003828_pulmonary_edema | 0.63198167 |
| 83 | MP0006138_congestive_heart_failure | 0.62884089 |
| 84 | MP0000767_abnormal_smooth_muscle | 0.62572755 |
| 85 | MP0002078_abnormal_glucose_homeostasis | 0.61633050 |
| 86 | MP0003279_aneurysm | 0.61477598 |
| 87 | MP0002168_other_aberrant_phenotype | 0.60861137 |
| 88 | MP0001533_abnormal_skeleton_physiology | 0.60228753 |
| 89 | * MP0002136_abnormal_kidney_physiology | 0.59996986 |
| 90 | MP0009780_abnormal_chondrocyte_physiolo | 0.57647215 |
| 91 | MP0001243_abnormal_dermal_layer | 0.56923457 |
| 92 | MP0005535_abnormal_body_temperature | 0.55689466 |
| 93 | MP0005408_hypopigmentation | 0.54803471 |
| 94 | MP0004272_abnormal_basement_membrane | 0.54537244 |
| 95 | MP0002876_abnormal_thyroid_physiology | 0.54361695 |
| 96 | MP0001542_abnormal_bone_strength | 0.54272551 |
| 97 | MP0008775_abnormal_heart_ventricle | 0.53782349 |
| 98 | MP0000467_abnormal_esophagus_morphology | 0.53447123 |
| 99 | MP0008004_abnormal_stomach_pH | 0.52762974 |
| 100 | MP0005595_abnormal_vascular_smooth | 0.52742951 |
| 101 | MP0000230_abnormal_systemic_arterial | 0.52684210 |
| 102 | MP0003638_abnormal_response/metabolism_ | 0.50155688 |
| 103 | MP0001851_eye_inflammation | 0.49920216 |
| 104 | MP0002332_abnormal_exercise_endurance | 0.49818291 |
| 105 | MP0005395_other_phenotype | 0.49661397 |
| 106 | MP0002896_abnormal_bone_mineralization | 0.49058325 |
| 107 | MP0005187_abnormal_penis_morphology | 0.48580437 |
| 108 | MP0003300_gastrointestinal_ulcer | 0.47409787 |
| 109 | MP0001958_emphysema | 0.47137833 |
| 110 | MP0004782_abnormal_surfactant_physiolog | 0.46151979 |
| 111 | MP0002108_abnormal_muscle_morphology | 0.45808256 |
| 112 | MP0002837_dystrophic_cardiac_calcinosis | 0.45259180 |
| 113 | MP0005666_abnormal_adipose_tissue | 0.45005983 |
| 114 | * MP0001845_abnormal_inflammatory_respons | 0.44074865 |
| 115 | MP0001915_intracranial_hemorrhage | 0.43533789 |
| 116 | MP0000343_altered_response_to | 0.43058185 |
| 117 | MP0006054_spinal_hemorrhage | 0.42752446 |
| 118 | MP0008873_increased_physiological_sensi | 0.42705217 |
| 119 | MP0009115_abnormal_fat_cell | 0.42537674 |
| 120 | MP0008874_decreased_physiological_sensi | 0.42217017 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.08516817 |
| 2 | * Complement deficiency (HP:0004431) | 6.78032401 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 6.57273783 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.23789634 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.14551701 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.97730485 |
| 7 | Xanthomatosis (HP:0000991) | 5.91626473 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 5.49718853 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 5.45433900 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 5.02921646 |
| 11 | * Abnormality of complement system (HP:0005339) | 4.98038419 |
| 12 | Joint hemorrhage (HP:0005261) | 4.89711288 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.62274521 |
| 14 | Hypolipoproteinemia (HP:0010981) | 4.34104763 |
| 15 | Epidermoid cyst (HP:0200040) | 4.24938698 |
| 16 | Hyperammonemia (HP:0001987) | 4.10115274 |
| 17 | Hypoalphalipoproteinemia (HP:0003233) | 4.04678389 |
| 18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.03889549 |
| 19 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.95756659 |
| 20 | Abnormality of methionine metabolism (HP:0010901) | 3.83944650 |
| 21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.81387925 |
| 22 | Hyperglycinemia (HP:0002154) | 3.77753753 |
| 23 | Ketosis (HP:0001946) | 3.75480823 |
| 24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.74532235 |
| 25 | Abnormality of the intrinsic pathway (HP:0010989) | 3.71614179 |
| 26 | Myocardial infarction (HP:0001658) | 3.70744258 |
| 27 | Fat malabsorption (HP:0002630) | 3.68214876 |
| 28 | * Glomerulonephritis (HP:0000099) | 3.63067621 |
| 29 | Hypoglycemic coma (HP:0001325) | 3.50940304 |
| 30 | Hyperglycinuria (HP:0003108) | 3.49313452 |
| 31 | Hypercholesterolemia (HP:0003124) | 3.37571001 |
| 32 | Abnormality of glycine metabolism (HP:0010895) | 3.37496918 |
| 33 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.37496918 |
| 34 | Conjugated hyperbilirubinemia (HP:0002908) | 3.31587336 |
| 35 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.30326227 |
| 36 | Spontaneous abortion (HP:0005268) | 3.19251745 |
| 37 | Skin nodule (HP:0200036) | 3.18193013 |
| 38 | Hepatocellular carcinoma (HP:0001402) | 3.12375298 |
| 39 | Mitral stenosis (HP:0001718) | 3.02129275 |
| 40 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.00200460 |
| 41 | Amyloidosis (HP:0011034) | 2.90158500 |
| 42 | Hyperbilirubinemia (HP:0002904) | 2.87758293 |
| 43 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.83468445 |
| 44 | Delayed CNS myelination (HP:0002188) | 2.80405146 |
| 45 | Ketoacidosis (HP:0001993) | 2.80299444 |
| 46 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.78735664 |
| 47 | Abnormality of nucleobase metabolism (HP:0010932) | 2.75978951 |
| 48 | Vascular calcification (HP:0004934) | 2.72864592 |
| 49 | Steatorrhea (HP:0002570) | 2.69927765 |
| 50 | Abnormal delivery (HP:0001787) | 2.67718218 |
| 51 | Premature rupture of membranes (HP:0001788) | 2.64756579 |
| 52 | Cardiovascular calcification (HP:0011915) | 2.63144267 |
| 53 | Abnormality of serum amino acid levels (HP:0003112) | 2.55146336 |
| 54 | Aortic dissection (HP:0002647) | 2.52842593 |
| 55 | * Nephritis (HP:0000123) | 2.50552204 |
| 56 | Esophageal varix (HP:0002040) | 2.49276467 |
| 57 | Abnormality of purine metabolism (HP:0004352) | 2.48805313 |
| 58 | Hypochromic microcytic anemia (HP:0004840) | 2.39536103 |
| 59 | Purpura (HP:0000979) | 2.36089952 |
| 60 | Metabolic acidosis (HP:0001942) | 2.34739144 |
| 61 | Gingival bleeding (HP:0000225) | 2.31708817 |
| 62 | Vascular tortuosity (HP:0004948) | 2.27841526 |
| 63 | Aortic aneurysm (HP:0004942) | 2.27625791 |
| 64 | Dicarboxylic aciduria (HP:0003215) | 2.22831635 |
| 65 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.22831635 |
| 66 | Osteomalacia (HP:0002749) | 2.21919121 |
| 67 | Hypoglycemic seizures (HP:0002173) | 2.17483370 |
| 68 | Thrombophlebitis (HP:0004418) | 2.16516497 |
| 69 | Hypophosphatemic rickets (HP:0004912) | 2.16024057 |
| 70 | Hemorrhage of the eye (HP:0011885) | 2.13342008 |
| 71 | Arterial tortuosity (HP:0005116) | 2.11487280 |
| 72 | Gout (HP:0001997) | 2.10728932 |
| 73 | Menorrhagia (HP:0000132) | 2.06909534 |
| 74 | Acanthocytosis (HP:0001927) | 2.06349670 |
| 75 | Peritonitis (HP:0002586) | 2.06095928 |
| 76 | Abnormality of proline metabolism (HP:0010907) | 2.05457593 |
| 77 | Hydroxyprolinuria (HP:0003080) | 2.05457593 |
| 78 | Spastic diplegia (HP:0001264) | 2.04584236 |
| 79 | Wrist flexion contracture (HP:0001239) | 2.03897199 |
| 80 | Lethargy (HP:0001254) | 2.03681729 |
| 81 | Malnutrition (HP:0004395) | 2.03190478 |
| 82 | Abnormal gallbladder morphology (HP:0012437) | 2.02115152 |
| 83 | Abnormality of iron homeostasis (HP:0011031) | 2.01885467 |
| 84 | Sensorimotor neuropathy (HP:0007141) | 2.01303156 |
| 85 | Joint swelling (HP:0001386) | 2.00265372 |
| 86 | Abnormal cartilage morphology (HP:0002763) | 1.99638267 |
| 87 | Neonatal onset (HP:0003623) | 1.98993862 |
| 88 | Cholelithiasis (HP:0001081) | 1.97926863 |
| 89 | Irritability (HP:0000737) | 1.97759649 |
| 90 | Arthropathy (HP:0003040) | 1.95425157 |
| 91 | Pancreatitis (HP:0001733) | 1.95142381 |
| 92 | Rickets (HP:0002748) | 1.91314465 |
| 93 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.90404730 |
| 94 | Generalized aminoaciduria (HP:0002909) | 1.88957263 |
| 95 | Polycythemia (HP:0001901) | 1.87265487 |
| 96 | Vertebral compression fractures (HP:0002953) | 1.87122728 |
| 97 | Enlarged kidneys (HP:0000105) | 1.85625599 |
| 98 | Epistaxis (HP:0000421) | 1.82789717 |
| 99 | Cholecystitis (HP:0001082) | 1.82194460 |
| 100 | Abnormal gallbladder physiology (HP:0012438) | 1.82194460 |
| 101 | Stroke (HP:0001297) | 1.81623845 |
| 102 | Spontaneous hematomas (HP:0007420) | 1.81031628 |
| 103 | Protrusio acetabuli (HP:0003179) | 1.80578391 |
| 104 | Vomiting (HP:0002013) | 1.79711622 |
| 105 | Pulmonary embolism (HP:0002204) | 1.78206447 |
| 106 | Fair hair (HP:0002286) | 1.78048818 |
| 107 | Late onset (HP:0003584) | 1.77571939 |
| 108 | Elevated alkaline phosphatase (HP:0003155) | 1.76066134 |
| 109 | Abnormality of the Achilles tendon (HP:0005109) | 1.75183971 |
| 110 | Increased serum ferritin (HP:0003281) | 1.73409697 |
| 111 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.72764150 |
| 112 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.69785379 |
| 113 | Broad metatarsal (HP:0001783) | 1.69181781 |
| 114 | Alkalosis (HP:0001948) | 1.69024116 |
| 115 | Striae distensae (HP:0001065) | 1.68094559 |
| 116 | Osteolytic defects of the hand bones (HP:0009699) | 1.65858041 |
| 117 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.65858041 |
| 118 | Axonal loss (HP:0003447) | 1.64802667 |
| 119 | Soft skin (HP:0000977) | 1.64689593 |
| 120 | Abnormality of the gallbladder (HP:0005264) | 1.64504928 |
| 121 | Periodontitis (HP:0000704) | 1.64310844 |
| 122 | Cerebral palsy (HP:0100021) | 1.64135447 |
| 123 | Opisthotonus (HP:0002179) | 1.63680734 |
| 124 | Hyperglycemia (HP:0003074) | 1.62926532 |
| 125 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.60843426 |
| 126 | Mucopolysacchariduria (HP:0008155) | 1.60843426 |
| 127 | Atrioventricular block (HP:0001678) | 1.59077528 |
| 128 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.58868293 |
| 129 | Blue sclerae (HP:0000592) | 1.57647784 |
| 130 | Cerebral aneurysm (HP:0004944) | 1.57495734 |
| 131 | Joint stiffness (HP:0001387) | 1.56730892 |
| 132 | Back pain (HP:0003418) | 1.56219272 |
| 133 | Abnormality of vitamin metabolism (HP:0100508) | 1.49126532 |
| 134 | Aneurysm (HP:0002617) | 1.48322638 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.53326620 |
| 2 | ERN1 | 4.19667907 |
| 3 | TGFBR2 | 3.63206969 |
| 4 | FGFR4 | 3.58900765 |
| 5 | SIK1 | 3.29812403 |
| 6 | INSRR | 2.70294630 |
| 7 | TYK2 | 2.39646720 |
| 8 | TAOK3 | 2.39242973 |
| 9 | NEK9 | 2.28009851 |
| 10 | MST1R | 2.17374322 |
| 11 | ERBB4 | 2.13572148 |
| 12 | LATS1 | 2.00441173 |
| 13 | TIE1 | 1.89794058 |
| 14 | TRPM7 | 1.80716778 |
| 15 | CAMK1D | 1.80524584 |
| 16 | DDR2 | 1.72223327 |
| 17 | PIK3CG | 1.67169905 |
| 18 | PKN2 | 1.65421185 |
| 19 | TRIB3 | 1.61227342 |
| 20 | FRK | 1.60483787 |
| 21 | JAK1 | 1.56334094 |
| 22 | FLT3 | 1.47587708 |
| 23 | MAPK15 | 1.47315732 |
| 24 | PTK6 | 1.46122556 |
| 25 | MAPK11 | 1.43870258 |
| 26 | NTRK1 | 1.42303188 |
| 27 | MAP3K14 | 1.39612290 |
| 28 | MAP2K4 | 1.37145166 |
| 29 | PDGFRA | 1.32646546 |
| 30 | KDR | 1.31654529 |
| 31 | EPHB1 | 1.26623615 |
| 32 | JAK2 | 1.26020225 |
| 33 | CAMK1G | 1.24159621 |
| 34 | FGFR2 | 1.22519831 |
| 35 | CSK | 1.18654815 |
| 36 | PDK2 | 1.17953952 |
| 37 | EPHA3 | 1.17554981 |
| 38 | DAPK2 | 1.16901844 |
| 39 | PRKAA2 | 1.16793973 |
| 40 | MYLK | 1.15095022 |
| 41 | MAPKAPK3 | 1.14441415 |
| 42 | MAP3K7 | 1.13783231 |
| 43 | MAP3K2 | 1.10582525 |
| 44 | RIPK1 | 1.08983161 |
| 45 | TBK1 | 1.08291027 |
| 46 | FGFR3 | 1.08095889 |
| 47 | GRK7 | 1.06161318 |
| 48 | MAPK12 | 1.00902612 |
| 49 | ABL2 | 0.96380311 |
| 50 | MET | 0.96205905 |
| 51 | CDC42BPA | 0.95231552 |
| 52 | SGK3 | 0.93985891 |
| 53 | IRAK3 | 0.90659843 |
| 54 | MAPK7 | 0.90349504 |
| 55 | LATS2 | 0.87556433 |
| 56 | CSF1R | 0.87097428 |
| 57 | PINK1 | 0.86284402 |
| 58 | GSK3A | 0.83302715 |
| 59 | STK38L | 0.78660248 |
| 60 | MAP2K3 | 0.78149874 |
| 61 | MAPK4 | 0.77377137 |
| 62 | EEF2K | 0.76804759 |
| 63 | IKBKE | 0.76618712 |
| 64 | MUSK | 0.75610376 |
| 65 | CAMK4 | 0.74719121 |
| 66 | JAK3 | 0.73368785 |
| 67 | SGK2 | 0.73333196 |
| 68 | ERBB2 | 0.73055872 |
| 69 | EIF2AK3 | 0.72141392 |
| 70 | CDK6 | 0.71507284 |
| 71 | IGF1R | 0.67776192 |
| 72 | PRPF4B | 0.67311785 |
| 73 | PRKG2 | 0.67160287 |
| 74 | PRKCZ | 0.66752277 |
| 75 | ZAP70 | 0.66462615 |
| 76 | TTN | 0.65685007 |
| 77 | FER | 0.65617575 |
| 78 | TGFBR1 | 0.63743216 |
| 79 | ICK | 0.63385518 |
| 80 | KIT | 0.60227687 |
| 81 | AKT3 | 0.59530244 |
| 82 | PRKACG | 0.58638352 |
| 83 | OBSCN | 0.56202689 |
| 84 | MAP2K1 | 0.54659751 |
| 85 | MAP3K3 | 0.52731926 |
| 86 | CAMK2G | 0.52622493 |
| 87 | MOS | 0.52350643 |
| 88 | PRKAA1 | 0.52309865 |
| 89 | PKN1 | 0.51835273 |
| 90 | MAP3K1 | 0.51603453 |
| 91 | IKBKB | 0.50175746 |
| 92 | PIK3CA | 0.49872436 |
| 93 | MAP3K6 | 0.49858374 |
| 94 | LMTK2 | 0.49541014 |
| 95 | PAK4 | 0.49395968 |
| 96 | PRKG1 | 0.48480260 |
| 97 | CHUK | 0.47805414 |
| 98 | SCYL2 | 0.47479941 |
| 99 | PAK2 | 0.47467170 |
| 100 | SRC | 0.47032659 |
| 101 | BLK | 0.46778689 |
| 102 | PDPK1 | 0.44353584 |
| 103 | EGFR | 0.43952664 |
| 104 | MAPKAPK5 | 0.43770556 |
| 105 | PRKCH | 0.43299251 |
| 106 | SGK223 | 0.43169034 |
| 107 | SGK494 | 0.43169034 |
| 108 | STK3 | 0.42688059 |
| 109 | PTK2 | 0.42496655 |
| 110 | NTRK3 | 0.41847775 |
| 111 | PRKD1 | 0.41632718 |
| 112 | TEC | 0.41568069 |
| 113 | STK38 | 0.41040556 |
| 114 | GRK1 | 0.40709813 |
| 115 | DYRK1B | 0.40201935 |
| 116 | IRAK1 | 0.39333629 |
| 117 | MAP3K12 | 0.38774885 |
| 118 | ABL1 | 0.38679666 |
| 119 | PDGFRB | 0.37174271 |
| 120 | MAP3K10 | 0.36324459 |
| 121 | MAP2K2 | 0.35368336 |
| 122 | RET | 0.34717004 |
| 123 | PRKCE | 0.34292650 |
| 124 | EPHA2 | 0.33945837 |
| 125 | EPHB2 | 0.33652455 |
| 126 | NUAK1 | 0.33565501 |
| 127 | MAPK3 | 0.33061710 |
| 128 | ADRBK1 | 0.31989923 |
| 129 | ACVR1B | 0.31587181 |
| 130 | PRKCQ | 0.30820095 |
| 131 | PDK1 | 0.30777824 |
| 132 | IRAK4 | 0.27408066 |
| 133 | MTOR | 0.26756368 |
| 134 | NLK | 0.25600456 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.42895684 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.71036311 |
| 3 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.26477692 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.26169657 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.17257621 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.92151838 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.64692737 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.56019369 |
| 9 | * Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.51146017 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47462930 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.41212472 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.35190021 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.25095925 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.24863142 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.11439679 |
| 16 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.00157307 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 1.96219262 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.94534488 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.94193431 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.92068441 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.89760787 |
| 22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.89276925 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.82147843 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.80748483 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.80705050 |
| 26 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.78687766 |
| 27 | Retinol metabolism_Homo sapiens_hsa00830 | 1.72848052 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.69887203 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.57620849 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.55551344 |
| 31 | Bile secretion_Homo sapiens_hsa04976 | 1.48866387 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.47791606 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.39405746 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.39029199 |
| 35 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.37615140 |
| 36 | ABC transporters_Homo sapiens_hsa02010 | 1.36404800 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.33212716 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.32049257 |
| 39 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.30884415 |
| 40 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.24040948 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.22762832 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.15493728 |
| 43 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.08410748 |
| 44 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.06851779 |
| 45 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.04509823 |
| 46 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.02747435 |
| 47 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.99273891 |
| 48 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.98543288 |
| 49 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.97599643 |
| 50 | Carbon metabolism_Homo sapiens_hsa01200 | 0.93955943 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.93476817 |
| 52 | Lysine degradation_Homo sapiens_hsa00310 | 0.93475249 |
| 53 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.93156730 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.86772501 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.85132913 |
| 56 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.83067923 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.79346222 |
| 58 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.78379500 |
| 59 | Prion diseases_Homo sapiens_hsa05020 | 0.71483679 |
| 60 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.66475198 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.59831350 |
| 62 | Sulfur relay system_Homo sapiens_hsa04122 | 0.53841588 |
| 63 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50683838 |
| 64 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.49273300 |
| 65 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.44879931 |
| 66 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.41904790 |
| 67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38870675 |
| 68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.37267542 |
| 69 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.35334754 |
| 70 | Metabolic pathways_Homo sapiens_hsa01100 | 0.34022605 |
| 71 | Insulin resistance_Homo sapiens_hsa04931 | 0.32017756 |
| 72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.29662059 |
| 73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.21441500 |
| 74 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.18172199 |
| 75 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.17748703 |
| 76 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.15201542 |
| 77 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.15081461 |
| 78 | Pertussis_Homo sapiens_hsa05133 | 0.15065395 |
| 79 | Focal adhesion_Homo sapiens_hsa04510 | 0.14272052 |
| 80 | Lysosome_Homo sapiens_hsa04142 | 0.13023277 |
| 81 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.11745770 |
| 82 | Other glycan degradation_Homo sapiens_hsa00511 | 0.11224722 |
| 83 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.08966334 |
| 84 | Amoebiasis_Homo sapiens_hsa05146 | 0.08096397 |
| 85 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.07856202 |
| 86 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.06857131 |
| 87 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.04257802 |
| 88 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.03907634 |
| 89 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.03054284 |
| 90 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02332477 |
| 91 | Circadian rhythm_Homo sapiens_hsa04710 | 0.00814691 |
| 92 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.00734422 |
| 93 | Mineral absorption_Homo sapiens_hsa04978 | -0.1598891 |
| 94 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1541614 |
| 95 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | -0.1504389 |
| 96 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1348998 |
| 97 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1118701 |
| 98 | Hepatitis C_Homo sapiens_hsa05160 | -0.1110348 |
| 99 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | -0.1082138 |
| 100 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1038702 |
| 101 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0961678 |
| 102 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0906329 |
| 103 | Platelet activation_Homo sapiens_hsa04611 | -0.0574870 |
| 104 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0557105 |
| 105 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | -0.0536831 |
| 106 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | -0.0497872 |
| 107 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0302270 |
| 108 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | -0.0192360 |
| 109 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0071705 |
| 110 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0045377 |
| 111 | Malaria_Homo sapiens_hsa05144 | -0.0037864 |

